Raymond James & Associates’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4
| Closed | -$40K | – | 3584 |
|
|
2018
Q1 | $40K | Hold |
4
| – | – | ﹤0.01% | 3294 |
|
|
2017
Q4 | $61K | Sell |
4
-1
| -20% | -$15.3K | ﹤0.01% | 3207 |
|
|
2017
Q3 | $126K | Buy |
5
+2
| +67% | +$50.4K | ﹤0.01% | 3119 |
|
|
2017
Q2 | $139K | Sell |
3
-3
| -50% | -$139K | ﹤0.01% | 3038 |
|
|
2017
Q1 | $461K | Buy |
6
+2
| +50% | +$154K | ﹤0.01% | 2423 |
|
|
2016
Q4 | $344K | Hold |
4
| – | – | ﹤0.01% | 2544 |
|
|
2016
Q3 | $456K | Buy |
4
+2
| +100% | +$228K | ﹤0.01% | 2343 |
|
|
2016
Q2 | $174K | Buy |
2
+1
| +100% | +$87K | ﹤0.01% | 2686 |
|
|
2016
Q1 | $184K | Buy |
+1
| New | +$184K | ﹤0.01% | 2588 |
|